Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Rupintrivir

(Synonyms: Rupintrivirvr, AG-7088, AG7088) Copy Product Info
🥰Excellent

Synonyms: Rupintrivirvr, AG-7088, AG7088

Catalog No. T16809 Copy Product Info
Purity: 99.35%
🥰Excellent
Rupintrivir (AG7088) is an antiviral agent and an irreversible inhibitor targeting human rhinovirus 3C protease (EC50 = 0.023 μM), featuring high selectivity and immunomodulatory activity, capable of effectively inhibiting multiple HRV serotypes as well as EV71 and EV-D68 replication, commonly used for research on viral infection mechanisms.
Rupintrivir
Cas No. 223537-30-2
TargetMol | Customer service
Customer service consultation
Pack SizePriceUSA StockGlobal StockQuantity
1 mg$118In StockIn Stock
5 mg$263In StockIn Stock
10 mg$419In StockIn Stock
25 mg$737In StockIn Stock
50 mg$977-In Stock
100 mg$1,290-In Stock
1 mL x 10 mM (in DMSO)$347In StockIn Stock
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.35%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Rupintrivir (AG7088) is an antiviral agent and an irreversible inhibitor targeting human rhinovirus 3C protease (EC50 = 0.023 μM), featuring high selectivity and immunomodulatory activity, capable of effectively inhibiting multiple HRV serotypes as well as EV71 and EV-D68 replication, commonly used for research on viral infection mechanisms.
Targets & IC50
RD cells:0.009 μM (EC50), H1-HeLa cells:14 nM (EC50), rhinovirus (HRV) 3C cysteine protease mimetic peptide:0.023 μM (EC50), Vero cells:0.419 μM (EC50), HeLa cells:0.27 μM (EC50)
In vitro
Methods: RD cells were incubated with gradient concentrations of Rupintrivir for 3–4 days.
Results: Rupintrivir showed potent inhibition against EV-D68, RV-87, and EV-71, with EC₅₀ of 0.0022–0.0053 μM and EC₉₀ of 0.004 μM against EV-D68, demonstrating the strongest activity among ten tested compounds. [1]
Methods: A fluorescence resonance energy transfer (FRET) assay was used. Gradient concentrations of Rupintrivir were co-incubated with purified DHAV 3C protease and fluorescent substrate for 2 hours.
Results: It showed inhibitory activity against duck hepatitis A virus 3C protease. [2]
In vivo
Methods: Precision-cut lung slices were prepared from HDM-sensitized Balb/c mice, infected ex vivo with RV1b (10⁵ TCID₅₀/mL), and treated with 100 nM Rupintrivir for 48 hours.
Results: Rupintrivir significantly inhibited RV-induced excessive secretion of IL-4 and IL-6 in the HDM-sensitized group without affecting interferon responses. [3]
SynonymsRupintrivirvr, AG-7088, AG7088
Chemical Properties
Molecular Weight598.66
FormulaC31H39FN4O7
Cas No.223537-30-2
SmilesCCOC(=O)\C=C\[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@@H](CC(=O)[C@@H](NC(=O)c1cc(C)on1)C(C)C)Cc1ccc(F)cc1
Relative Density.1.31g/cm3
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 252.5 mg/mL (421.78 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+90% Corn Oil: 2 mg/mL (3.34 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.6704 mL8.3520 mL16.7040 mL83.5199 mL
5 mM0.3341 mL1.6704 mL3.3408 mL16.7040 mL
10 mM0.1670 mL0.8352 mL1.6704 mL8.3520 mL
20 mM0.0835 mL0.4176 mL0.8352 mL4.1760 mL
50 mM0.0334 mL0.1670 mL0.3341 mL1.6704 mL
100 mM0.0167 mL0.0835 mL0.1670 mL0.8352 mL
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 µL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 µL Tween 80 and mix well until fully clarified.

3) Add 450 µL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
µL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: Rupintrivir chemical structure | Rupintrivir in vivo | Rupintrivir in vitro | Rupintrivir formula | Rupintrivir molecular weight